FATE FATE THERAPEUTICS INC
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $155.6M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $10.1M |
| 2022-Q2 | $0 | $3.2M |
| 2022-Q3 | $0 | $2.2M |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $698.1K | $455.6K |
| 2023-Q2 | $1.9M | $1.8M |
| 2023-Q3 | $0 | $59.4K |
| 2023-Q4 | $166.0K | $64.0K |
| 2024-Q1 | $0 | $237.7K |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $2.7K |
| 2024-Q4 | $668.6K | $573.9K |
| 2025-Q1 | $0 | $31.4K |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $24.9K |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $16.8K |
| 2026-Q2 | $0 | $102.5K |
| 2026-Q3 | $0 | $203.5K |
| 2026-Q4 | $0 | $13.5K |
Bought$3.4M7 buy days
Sold$22.8M70 sell days
Net insider flow-$19.4Mnet selling · 5 years
Latest trade2026-11-03Adawi Kamal
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-03 | Sell | Adawi Kamal | CFO | 6,582 | $2.05 | $13.5K | 1 |
| 2026-08-04 | Sell | Valamehr Bahram | CEO | 43,947 | $2.46 | $108.1K | 1 |
| 2026-08-04 | Sell | TAHL CINDY | Other officer | 38,800 | $2.46 | $95.4K | 1 |
| 2026-05-20 | Sell | Valamehr Bahram | CEO | 28,946 | $1.88 | $54.4K | 1 |
| 2026-05-20 | Sell | TAHL CINDY | Other officer | 25,590 | $1.88 | $48.1K | 1 |
| 2026-01-09 | Sell | TAHL CINDY | Other officer | 10,589 | $1.06 | $11.2K | 1 |
| 2026-01-09 | Sell | Valamehr Bahram | CEO | 5,190 | $1.07 | $5.6K | 1 |
| 2025-08-04 | Sell | Valamehr Bahram | CEO | 14,466 | $1.06 | $15.3K | 1 |
| 2025-08-04 | Sell | TAHL CINDY | Other officer | 9,037 | $1.06 | $9.6K | 1 |
| 2025-01-10 | Sell | Valamehr Bahram | CEO | 8,705 | $1.54 | $13.4K | 1 |
| 2025-01-10 | Sell | Bressi Jerome Charles | Other officer | 5,980 | $1.55 | $9.3K | 1 |
| 2025-01-10 | Sell | TAHL CINDY | Other officer | 5,654 | $1.55 | $8.8K | 1 |
| 2024-12-20 | Buy | Green Jeremy | Director | 397,964 | $1.68 | $668.6K | 1 |
| 2024-12-20 | Sell | Green Jeremy | Director | 341,633 | $1.68 | $573.9K | 1 |
| 2024-08-06 | Sell | Xu Yuan | Director | 633 | $4.23 | $2.7K | 1 |
| 2024-03-04 | Sell | Dulac Edward J III | CFO | 2,447 | $7.77 | $19.0K | 1 |
| 2024-01-29 | Sell | Dulac Edward J III | CFO | 1,849 | $5.00 | $9.2K | 1 |
| 2024-01-09 | Sell | Wolchko J Scott | CEO | 14,391 | $4.37 | $62.9K | 1 |
| 2024-01-09 | Sell | Valamehr Bahram | Other C-suite | 11,271 | $4.38 | $49.4K | 1 |
| 2024-01-09 | Sell | TAHL CINDY | General counsel | 10,874 | $4.37 | $47.5K | 1 |
| 2024-01-09 | Sell | Dulac Edward J III | CFO | 7,028 | $4.37 | $30.7K | 1 |
| 2024-01-02 | Sell | Dulac Edward J III | CFO | 5,182 | $3.66 | $19.0K | 1 |
| 2023-12-26 | Buy | Green Jeremy | Director | 44,630 | $3.72 | $166.0K | 1 |
| 2023-12-18 | Sell | Dulac Edward J III | CFO | 1,585 | $3.50 | $5.5K | 1 |
| 2023-11-09 | Sell | TAHL CINDY | General counsel | 24,363 | $2.40 | $58.5K | 1 |
| 2023-08-18 | Sell | Dulac Edward J III | CFO | 4,718 | $2.80 | $13.2K | 1 |
| 2023-08-04 | Sell | Xu Yuan | Director | 632 | $3.71 | $2.3K | 1 |
| 2023-07-05 | Sell | Dulac Edward J III | CFO | 5,182 | $4.83 | $25.0K | 1 |
| 2023-07-05 | Sell | Powl Brian T. | Other C-suite | 3,854 | $4.87 | $18.8K | 1 |
| 2023-06-14 | Sell | Xu Yuan | Director | 3,460 | $5.58 | $19.3K | 1 |
| 2023-04-21 | Buy | Green Jeremy | Director | 256,639 | $6.18 | $1.6M | 1 |
| 2023-04-20 | Buy | Green Jeremy | Director | 20,000 | $5.99 | $119.8K | 1 |
| 2023-04-18 | Sell | Chu Yu-Waye | Other C-suite | 2,532 | $6.57 | $16.6K | 2 |
| 2023-04-14 | Sell | Green Jeremy | Director | 302,339 | $5.84 | $1.8M | 1 |
| 2023-04-14 | Buy | Green Jeremy | Director | 25,700 | $6.00 | $154.2K | 1 |
| 2023-01-13 | Buy | MENDLEIN JOHN | Director | 36,631 | $5.43 | $198.9K | 1 |
| 2023-01-11 | Buy | MENDLEIN JOHN | Director | 88,048 | $5.67 | $499.2K | 1 |
| 2023-01-10 | Sell | Wolchko J Scott | CEO | 45,907 | $5.24 | $240.6K | 1 |
| 2023-01-10 | Sell | TAHL CINDY | General counsel | 11,553 | $5.24 | $60.5K | 1 |
| 2023-01-10 | Sell | Valamehr Bahram | Other C-suite | 10,917 | $5.24 | $57.2K | 1 |
| 2023-01-10 | Sell | Chu Yu-Waye | Other C-suite | 7,825 | $5.24 | $41.0K | 1 |
| 2023-01-10 | Sell | Dulac Edward J III | CFO | 7,331 | $5.24 | $38.4K | 1 |
| 2023-01-10 | Sell | Plavsic Mark | Other C-suite | 3,418 | $5.24 | $17.9K | 1 |
| 2022-08-18 | Sell | Dulac Edward J III | CFO | 5,135 | $29.81 | $153.1K | 2 |
| 2022-07-22 | Sell | Wolchko J Scott | CEO | 6,246 | $32.08 | $200.4K | 3 |
| 2022-07-21 | Sell | Wolchko J Scott | CEO | 30,000 | $32.88 | $986.4K | 2 |
| 2022-07-07 | Sell | Valamehr Bahram | Other C-suite | 17,158 | $30.23 | $518.7K | 1 |
| 2022-07-06 | Sell | Valamehr Bahram | Other C-suite | 7,842 | $30.07 | $235.8K | 1 |
| 2022-07-05 | Sell | Plavsic Mark | Other C-suite | 3,719 | $24.61 | $91.5K | 1 |
| 2022-06-07 | Sell | Agarwal Shefali | Director | 841 | $21.89 | $18.4K | 1 |
| 2022-06-03 | Sell | Jooss Karin | Director | 1,483 | $22.82 | $33.8K | 1 |
| 2022-06-03 | Sell | COUGHLIN TIMOTHY | Director | 1,439 | $22.81 | $32.8K | 1 |
| 2022-06-03 | Sell | MENDLEIN JOHN | Director | 1,364 | $22.79 | $31.1K | 1 |
| 2022-06-03 | Sell | Agarwal Shefali | Director | 807 | $22.80 | $18.4K | 1 |
| 2022-06-03 | Sell | HERSHBERG ROBERT | Director | 672 | $22.75 | $15.3K | 1 |
| 2022-06-01 | Sell | TAHL CINDY | General counsel | 25,000 | $22.96 | $574.0K | 1 |
| 2022-04-22 | Sell | Wolchko J Scott | CEO | 10,000 | $34.59 | $345.9K | 2 |
| 2022-04-21 | Sell | Wolchko J Scott | CEO | 30,000 | $35.00 | $1.0M | 4 |
| 2022-04-19 | Sell | Chu Yu-Waye | Other C-suite | 4,062 | $35.37 | $143.7K | 1 |
| 2022-04-01 | Sell | TAHL CINDY | General counsel | 25,000 | $38.85 | $971.2K | 1 |
| 2022-03-14 | Sell | Valamehr Bahram | Other C-suite | 25,000 | $31.07 | $776.7K | 5 |
| 2022-03-10 | Sell | MENDLEIN JOHN | Director | 31,562 | $35.02 | $1.1M | 2 |
| 2022-01-21 | Sell | Wolchko J Scott | CEO | 10,000 | $38.02 | $380.2K | 1 |
| 2022-01-20 | Sell | Wolchko J Scott | CEO | 30,000 | $40.21 | $1.2M | 1 |
| 2022-01-11 | Sell | Wolchko J Scott | CEO | 14,566 | $48.68 | $709.0K | 2 |
| 2022-01-11 | Sell | TAHL CINDY | General counsel | 5,419 | $48.53 | $263.0K | 2 |
| 2022-01-11 | Sell | Valamehr Bahram | Other C-suite | 4,570 | $48.50 | $221.7K | 2 |
| 2022-01-11 | Sell | Chu Yu-Waye | VP | 3,965 | $48.51 | $192.3K | 2 |
| 2022-01-11 | Sell | Dulac Edward J III | CFO | 1,770 | $48.45 | $85.8K | 2 |
| 2022-01-10 | Sell | Wolchko J Scott | CEO | 34,156 | $46.86 | $1.6M | 3 |
| 2022-01-10 | Sell | TAHL CINDY | General counsel | 7,738 | $46.43 | $359.3K | 2 |
| 2022-01-10 | Sell | Valamehr Bahram | Other C-suite | 5,596 | $46.38 | $259.6K | 2 |
| 2022-01-03 | Sell | TAHL CINDY | General counsel | 50,000 | $59.34 | $3.0M | 4 |
| 2021-12-20 | Sell | Dulac Edward J III | CFO | 15,977 | $60.00 | $958.6K | 1 |
| 2021-12-13 | Sell | Valamehr Bahram | Other C-suite | 25,000 | $47.66 | $1.2M | 5 |
| 2021-12-10 | Sell | Chu Yu-Waye | VP | 7,500 | $51.46 | $385.9K | 7 |
| 2021-11-18 | Sell | Wolchko J Scott | CEO | 20,000 | $54.27 | $1.1M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Wolchko J Scott | CEO | $0 | $7.9M | 2024-01-09 |
| TAHL CINDY | Other officer | $0 | $5.5M | 2026-08-04 |
| Green Jeremy | Director | $2.7M | $2.3M | 2024-12-20 |
| Valamehr Bahram | CEO | $0 | $3.5M | 2026-08-04 |
| MENDLEIN JOHN | Director | $698.1K | $1.1M | 2023-01-13 |
| Dulac Edward J III | CFO | $0 | $1.4M | 2024-03-04 |
| Chu Yu-Waye | Other C-suite | $0 | $779.6K | 2023-04-18 |
| Plavsic Mark | Other C-suite | $0 | $109.4K | 2023-01-10 |
| Agarwal Shefali | Director | $0 | $36.8K | 2022-06-07 |
| Jooss Karin | Director | $0 | $33.8K | 2022-06-03 |
| COUGHLIN TIMOTHY | Director | $0 | $32.8K | 2022-06-03 |
| Xu Yuan | Director | $0 | $24.3K | 2024-08-06 |
| Powl Brian T. | Other C-suite | $0 | $18.8K | 2023-07-05 |
| HERSHBERG ROBERT | Director | $0 | $15.3K | 2022-06-03 |
| Adawi Kamal | CFO | $0 | $13.5K | 2026-11-03 |
| Bressi Jerome Charles | Other officer | $0 | $9.3K | 2025-01-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2016-11-23 | 3 | $1.2M | 38 | -19.0% (-16.5% raw) | +33.2% (+38.4% raw) | +3.1% (+8.7% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.